ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 195 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $165,000 | -22.5% | 2,744 | +8.9% | 0.00% | -25.0% |
| Q2 2019 | $213,000 | -11.6% | 2,520 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $241,000 | +35.4% | 2,520 | 0.0% | 0.01% | +25.0% |
| Q4 2018 | $178,000 | -17.2% | 2,520 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $215,000 | +7.0% | 2,520 | +45.2% | 0.00% | 0.0% |
| Q2 2018 | $201,000 | +43.6% | 1,736 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $140,000 | +636.8% | 1,736 | +210.0% | 0.00% | +200.0% |
| Q4 2016 | $19,000 | – | 560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 936,777 | $53,218,000 | 16.69% |
| Fairmount Funds Management LLC | 316,952 | $18,006,000 | 6.55% |
| ARMISTICE CAPITAL, LLC | 1,836,000 | $104,303,000 | 1.77% |
| Soleus Capital Management, L.P. | 182,400 | $10,362,000 | 1.62% |
| Portland Global Advisors LLC | 62,635 | $3,558,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 40,000 | $2,263,000 | 0.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $113,336,000 | 0.53% |
| Yorktown Management & Research Co Inc | 10,400 | $591,000 | 0.44% |
| Hennion & Walsh Asset Management, Inc. | 120,240 | $6,831,000 | 0.36% |
| Virtus ETF Advisers LLC | 9,599 | $545,000 | 0.24% |